TY - JOUR
T1 - Presentation and outcome of frequent and rare sarcoma histologic subtypes
T2 - A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers
AU - Penel, Nicolas
AU - Coindre, Jean Michel
AU - Giraud, Antoine
AU - Terrier, Philippe
AU - Ranchere-Vince, Dominique
AU - Collin, Françoise
AU - Guellec, Sophie L.E.
AU - Bazille, Céline
AU - Lae, Marick
AU - de Pinieux, Gonzague
AU - Ray-Coquard, Isabelle L.
AU - Bonvalot, Sylvie
AU - Cesne, Axel L.E.
AU - Robin, Yves Marie
AU - Stoeckle, Eberhardt
AU - Toulmonde, Maud
AU - Blay, Jean Yves
N1 - Publisher Copyright:
© 2017 American Cancer Society
PY - 2018/3/15
Y1 - 2018/3/15
N2 - BACKGROUND: The objective of this study was to describe characteristics at diagnosis and outcomes of adults with soft tissue sarcoma. METHODS: The authors conducted a retrospective multicenter study of 12,262 patients who were treated between January 1980 and 31 December 2013 in French Sarcoma Group centers and enrolled in the “Conticabase.” Diagnoses were systematically reviewed by expert pathologists, and entities were classified according to the 2013 World Health Organization classification. Diagnostic characteristics, treatments, and outcomes are described for the entire cohort, for the subgroup of patients with translocation-related sarcomas, and for 9 different histologic subtypes. RESULTS: The results stressed the magnitude of heterogeneity among adult sarcomas. For example, compared with other sarcomas, translocation-related sarcomas (2143 tumors; 20.8%) were associated with a younger age at presentation (40.6 vs 60.0 years; P <.0001), a low rate of predisposing conditions (0.01% vs 22.3%; P <.0001), a higher rate of lymph node involvement (4.7% vs 1.3%; P <.0001), and a higher rate of synchronous metastasis (11.9% vs 6.7%; P <.001); and complete (R0) resection (41.6% vs 31.9%; P <.0001), receipt of (neo)adjuvant radiation therapy (62.6% vs 42.2%; P <.0001), and receipt of (neo)adjuvant chemotherapy (36.6% vs 22.3%; P <.0001) were significantly more frequent. Overall, translocation-related sarcomas were associated with a lower rate of local relapse (18.1% vs 26.0%; P <.0001) but a higher rate of metastatic relapse (42.0% vs 30.7%; P <.0001). CONCLUSIONS: Collaborative efforts are urgently needed to better assess the natural history and management options for every histologic subtype of sarcoma. Cancer 2018;124:1179-87.
AB - BACKGROUND: The objective of this study was to describe characteristics at diagnosis and outcomes of adults with soft tissue sarcoma. METHODS: The authors conducted a retrospective multicenter study of 12,262 patients who were treated between January 1980 and 31 December 2013 in French Sarcoma Group centers and enrolled in the “Conticabase.” Diagnoses were systematically reviewed by expert pathologists, and entities were classified according to the 2013 World Health Organization classification. Diagnostic characteristics, treatments, and outcomes are described for the entire cohort, for the subgroup of patients with translocation-related sarcomas, and for 9 different histologic subtypes. RESULTS: The results stressed the magnitude of heterogeneity among adult sarcomas. For example, compared with other sarcomas, translocation-related sarcomas (2143 tumors; 20.8%) were associated with a younger age at presentation (40.6 vs 60.0 years; P <.0001), a low rate of predisposing conditions (0.01% vs 22.3%; P <.0001), a higher rate of lymph node involvement (4.7% vs 1.3%; P <.0001), and a higher rate of synchronous metastasis (11.9% vs 6.7%; P <.001); and complete (R0) resection (41.6% vs 31.9%; P <.0001), receipt of (neo)adjuvant radiation therapy (62.6% vs 42.2%; P <.0001), and receipt of (neo)adjuvant chemotherapy (36.6% vs 22.3%; P <.0001) were significantly more frequent. Overall, translocation-related sarcomas were associated with a lower rate of local relapse (18.1% vs 26.0%; P <.0001) but a higher rate of metastatic relapse (42.0% vs 30.7%; P <.0001). CONCLUSIONS: Collaborative efforts are urgently needed to better assess the natural history and management options for every histologic subtype of sarcoma. Cancer 2018;124:1179-87.
KW - database
KW - outcome
KW - reference centers
KW - soft tissue sarcoma
KW - translocation-related sarcoma
UR - http://www.scopus.com/inward/record.url?scp=85043349896&partnerID=8YFLogxK
U2 - 10.1002/cncr.31176
DO - 10.1002/cncr.31176
M3 - Article
C2 - 29211310
AN - SCOPUS:85043349896
SN - 0008-543X
VL - 124
SP - 1179
EP - 1187
JO - Cancer
JF - Cancer
IS - 6
ER -